These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Carroll IM; Andrus JM; Bruno-Bárcena JM; Klaenhammer TR; Hassan HM; Threadgill DS Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G729-38. PubMed ID: 17640978 [TBL] [Abstract][Full Text] [Related]
3. Effect of Lactobacillus plantarum LP-Onlly on gut flora and colitis in interleukin-10 knockout mice. Xia Y; Chen HQ; Zhang M; Jiang YQ; Hang XM; Qin HL J Gastroenterol Hepatol; 2011 Feb; 26(2):405-11. PubMed ID: 21261733 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model. del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117 [TBL] [Abstract][Full Text] [Related]
5. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice. Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449 [TBL] [Abstract][Full Text] [Related]
6. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties. Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413 [TBL] [Abstract][Full Text] [Related]
7. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197 [TBL] [Abstract][Full Text] [Related]
8. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Han W; Mercenier A; Ait-Belgnaoui A; Pavan S; Lamine F; van Swam II; Kleerebezem M; Salvador-Cartier C; Hisbergues M; Bueno L; Theodorou V; Fioramonti J Inflamm Bowel Dis; 2006 Nov; 12(11):1044-52. PubMed ID: 17075345 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis. Amit-Romach E; Uni Z; Reifen R Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675 [TBL] [Abstract][Full Text] [Related]
10. Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model. Tomusiak-Plebanek A; Heczko P; Skowron B; Baranowska A; Okoń K; Thor PJ; Strus M Drug Des Devel Ther; 2018; 12():3221-3233. PubMed ID: 30319243 [TBL] [Abstract][Full Text] [Related]
11. Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease. Feighery LM; Smith P; O'Mahony L; Fallon PG; Brayden DJ Dig Dis Sci; 2008 Sep; 53(9):2495-506. PubMed ID: 18157694 [TBL] [Abstract][Full Text] [Related]
13. Regional difference in the healing process of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats. Uchida M; Mogami O; Shimizu K; Matsueda K Inflammopharmacology; 2007 Aug; 15(4):158-63. PubMed ID: 17701018 [TBL] [Abstract][Full Text] [Related]
14. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats. Prakash A; Medhi B; Avti PK; Saikia UN; Pandhi P; Khanduja KL Phytother Res; 2008 Nov; 22(11):1511-9. PubMed ID: 18688794 [TBL] [Abstract][Full Text] [Related]
15. The role of superoxide dismutase in systemic inflammation. Maybauer MO; Maybauer DM; Herndon DN; Traber DL Shock; 2006 Feb; 25(2):206-7. PubMed ID: 16525361 [No Abstract] [Full Text] [Related]
16. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212 [TBL] [Abstract][Full Text] [Related]
17. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells. de Zoeten EF; Hancock WW Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583 [No Abstract] [Full Text] [Related]
18. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Andou A; Hisamatsu T; Okamoto S; Chinen H; Kamada N; Kobayashi T; Hashimoto M; Okutsu T; Shimbo K; Takeda T; Matsumoto H; Sato A; Ohtsu H; Suzuki M; Hibi T Gastroenterology; 2009 Feb; 136(2):564-74.e2. PubMed ID: 19027739 [TBL] [Abstract][Full Text] [Related]
19. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. Martin FP; Rezzi S; Philippe D; Tornier L; Messlik A; Hölzlwimmer G; Baur P; Quintanilla-Fend L; Loh G; Blaut M; Blum S; Kochhar S; Haller D J Proteome Res; 2009 May; 8(5):2376-87. PubMed ID: 19323467 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of dietary eicosapentaenoic acid- and oleic acid-induced modulation of colon inflammation in interleukin-10 gene-deficient mice. Knoch B; Barnett MP; Zhu S; Park ZA; Nones K; Dommels YE; Knowles SO; McNabb WC; Roy NC J Nutrigenet Nutrigenomics; 2009; 2(1):9-28. PubMed ID: 19776635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]